Cargando…
Omalizumab an effective and safe alternative therapy in severe refractory atopic dermatitis: A case report
RATIONALE: Atopic dermatitis is a frequent, relapsing, chronic inflammatory skin condition with a deep negative impact on quality of life. Three are the major pathological factors driving its complex pathogenesis: the skin barrier disruption, the altered Th2 cell response and itching. Current manage...
Autores principales: | Sirufo, Maria Maddalena, De Martinis, Massimo, Ginaldi, Lia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024249/ https://www.ncbi.nlm.nih.gov/pubmed/29901580 http://dx.doi.org/10.1097/MD.0000000000010897 |
Ejemplares similares
-
Successful Treatment With Omalizumab in a Child With Asthma and Urticaria: A Clinical Case Report
por: Sirufo, Maria Maddalena, et al.
Publicado: (2019) -
Sex, Allergic Diseases and Omalizumab
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022) -
Solar Urticaria, a Disease with Many Dark Sides: Is Omalizumab the Right Therapeutic Response? Reflections from a Clinical Case Report
por: De Martinis, Massimo, et al.
Publicado: (2019) -
Sex differences in the efficacy of omalizumab in the treatment of
chronic spontaneous urticaria
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022) -
Osteoporosis: Current and Emerging Therapies Targeted to Immunological Checkpoints
por: De Martinis, Massimo, et al.
Publicado: (2020)